Biochemical parameters in the assessment of anti-inflammatory drugs--a review.
D000208:Acute Disease; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001798:Blood Proteins; D001799:Blood Sedimentation; D002097:C-Reactive Protein; D002570:Ceruloplasmin; D002986:Clinical Trials as Topic; D003300:Copper / Q000097:blood; D005260:Female; D005340:Fibrinogen; D006046:Gold / Q000627:therapeutic use; D006242:Haptoglobins; D006801:Humans; D007136:Immunoglobulins; D010396:Penicillamine / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000276:immunology; D013438:Sulfhydryl Compounds / Q000097:blood; D014364:Tryptophan / Q000097:blood
D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D006242:Haptoglobins; D007136:Immunoglobulins; D013438:Sulfhydryl Compounds; D006046:Gold; D003300:Copper; D014364:Tryptophan; D005340:Fibrinogen; D002097:C-Reactive Protein; D012217:Rheumatoid Factor; D002570:Ceruloplasmin; D010396:Penicillamine